Type 1 diabetes and surgery in Turkey: checking what a proposal really means

An offer described as “diabetes surgery” must specify the type of diabetes and the exact intervention. A weight-loss operation, a pancreas transplant and an islet-cell procedure are not interchangeable treatments. For a person with type 1 diabetes, an advertisement promising a routine permanent cure is not enough evidence to book treatment or change insulin.

Check the diagnosis before discussing an operation

Bring the written diabetes diagnosis, treatment history and reports already used to establish the type. Tell the reviewing clinician if different doctors have recorded different types. Do not assume that using insulin means type 1 diabetes, or that a short advertising questionnaire can settle the diagnosis. The clinical team should clarify what is known before recommending a procedure.

Separate three different meanings of surgery

NIDDK: Pancreatic Islet Transplantation explains that type 1 diabetes involves loss of insulin-producing beta cells. Selected patients may be considered for islet or pancreas transplantation, but these are specialised treatments with substantial eligibility, donor and follow-up issues. Metabolic or bariatric surgery is a different pathway and must not be presented as a routine replacement for insulin treatment in type 1 diabetes. Ask the provider to write the proposed procedure’s precise name and purpose.

Ask who has evaluated the proposal

Request the name and specialty of the clinician who reviewed your records, the hospital responsible and the information on which the opinion is based. An appointment coordinator can organise communication but should not decide transplant eligibility. If a proposal mentions a clinical trial or cell therapy, ask whether it is standard treatment, approved use in that jurisdiction or research, and request documents that a qualified clinician can review. A publication about a treatment does not establish its availability to you in Turkey.

Evaluate the full trade-off

Ask what outcome is being sought: fewer severe low-glucose episodes, improved glucose management, reduced insulin requirements or another goal. These are different outcomes. For conventional donor-islet transplantation, immunosuppressive medicines are required while the transplanted islets function; the team should explain their risks and long-term monitoring. Investigational approaches may differ and must not be assumed to be available. The discussion should include what happens if the intended benefit does not occur or later diminishes, rather than only the most favourable patient story.

Protect continuity of current care

Do not stop or reduce insulin because of a sales message or an anticipated operation. Any changes require the treating diabetes team. Ask who will manage diabetes before, during and after any intervention, and who will be responsible once you return home. A travel package cannot replace this clinical handover.

Use a consultation to test the claim

A focused enquiry can attach the diagnosis and ask for a clinical explanation of the proposed intervention and its limitations. Through the contact page, you can ask about the appropriate assessment route; this article does not claim that Medicina Turkey offers pancreas or islet transplantation. The useful first outcome is a verified clinical opinion, which may conclude that the advertised procedure is inappropriate.